HRP970098B1 - Oxa- and thia-diazole muscarinic receptor antagonists - Google Patents

Oxa- and thia-diazole muscarinic receptor antagonists

Info

Publication number
HRP970098B1
HRP970098B1 HR970098A HRP970098A HRP970098B1 HR P970098 B1 HRP970098 B1 HR P970098B1 HR 970098 A HR970098 A HR 970098A HR P970098 A HRP970098 A HR P970098A HR P970098 B1 HRP970098 B1 HR P970098B1
Authority
HR
Croatia
Prior art keywords
diazole
thia
oxa
receptor antagonists
muscarinic receptor
Prior art date
Application number
HR970098A
Other languages
English (en)
Inventor
Alexander Roderick Mackenzie
Anthony Wood
Robert John Bass
Original Assignee
Pfizer Res And Dev Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res And Dev Company filed Critical Pfizer Res And Dev Company
Publication of HRP970098A2 publication Critical patent/HRP970098A2/hr
Publication of HRP970098B1 publication Critical patent/HRP970098B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR970098A 1996-02-22 1997-02-20 Oxa- and thia-diazole muscarinic receptor antagonists HRP970098B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9603755.1A GB9603755D0 (en) 1996-02-22 1996-02-22 Therapeutic agents

Publications (2)

Publication Number Publication Date
HRP970098A2 HRP970098A2 (en) 1999-04-30
HRP970098B1 true HRP970098B1 (en) 2001-12-31

Family

ID=10789217

Family Applications (1)

Application Number Title Priority Date Filing Date
HR970098A HRP970098B1 (en) 1996-02-22 1997-02-20 Oxa- and thia-diazole muscarinic receptor antagonists

Country Status (42)

Country Link
US (1) US5977142A (fr)
EP (1) EP0885218B1 (fr)
JP (1) JP3148252B2 (fr)
KR (1) KR100315934B1 (fr)
CN (1) CN1089340C (fr)
AP (1) AP751A (fr)
AR (1) AR005916A1 (fr)
AT (1) ATE200899T1 (fr)
AU (1) AU712230B2 (fr)
BG (2) BG102699A (fr)
BR (1) BR9707733A (fr)
CA (1) CA2247164C (fr)
CO (1) CO4650040A1 (fr)
CZ (1) CZ292650B6 (fr)
DE (1) DE69704701T2 (fr)
DK (1) DK0885218T3 (fr)
DZ (1) DZ2181A1 (fr)
ES (1) ES2156357T3 (fr)
GB (1) GB9603755D0 (fr)
GR (1) GR3036032T3 (fr)
HN (1) HN1997000020A (fr)
HR (1) HRP970098B1 (fr)
HU (1) HUP9900501A3 (fr)
ID (1) ID16642A (fr)
IL (1) IL125413A (fr)
IS (1) IS4803A (fr)
MY (1) MY129729A (fr)
NO (1) NO313414B1 (fr)
NZ (1) NZ331039A (fr)
OA (1) OA10838A (fr)
PE (1) PE42798A1 (fr)
PL (1) PL186879B1 (fr)
PT (1) PT885218E (fr)
RU (1) RU2162848C2 (fr)
SK (1) SK283461B6 (fr)
TN (1) TNSN97039A1 (fr)
TR (1) TR199801644T2 (fr)
TW (1) TW492961B (fr)
UA (1) UA61068C2 (fr)
WO (1) WO1997030994A1 (fr)
YU (1) YU35698A (fr)
ZA (1) ZA971513B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
CA2438991C (fr) * 2001-02-21 2010-08-17 Nps Pharmaceuticals, Inc. Composes heteropolycycliques et leur utilisations en tant qu'antagonistes des recepteurs metabotropiques du glutamate
GB0510141D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B3
GB0510139D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
WO2008017827A2 (fr) * 2006-08-08 2008-02-14 Argenta Discovery Limited Composés chimiques
JP2010501533A (ja) * 2006-08-21 2010-01-21 アージェンタ ディスカバリー リミテッド M3レセプター調節物質として有用な窒素含有複素環化合物
WO2008096093A1 (fr) * 2007-02-06 2008-08-14 Argenta Discovery Ltd. Dérivés d'oxazole et de thiazole et leurs utilisations
GB0702414D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd Oxazole and thiazole derivatives and their uses 2
GB0702385D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
BRPI0807004A2 (pt) * 2007-02-07 2014-04-15 Argenta Discovery Ltd Sal
GB0702382D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New salt
GB0702416D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
TW200843759A (en) * 2007-02-15 2008-11-16 Argenta Discovery Ltd Compounds and their use II
WO2009098453A1 (fr) * 2008-02-06 2009-08-13 Astrazeneca Ab Azonia bicycloalcanes comme antagonistes du récepteur d'acétylcholine muscarinique m3
US8263623B2 (en) 2008-07-11 2012-09-11 Pfizer Inc. Triazol derivatives useful for the treatment of diseases
WO2010018352A1 (fr) * 2008-08-12 2010-02-18 Argenta Discovery Limited Composés hétérocycliques utilisés dans le traitement de maladies impliquant l’activation améliorée du récepteur m3
JP2014065387A (ja) * 2012-09-25 2014-04-17 Showa Corp 自動二輪車の車高調整装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
IL88846A0 (en) * 1988-01-08 1989-07-31 Merck Sharp & Dohme Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
EP0619814A1 (fr) * 1991-12-31 1994-10-19 Fujisawa Pharmaceutical Co., Ltd. Derives d'oxadiazole a effet inhibiteur de l'acetylcholinesterase et agoniste muscarinique
TW360653B (en) * 1995-03-01 1999-06-11 Janssen Pharmaceutica Nv A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition

Also Published As

Publication number Publication date
CN1211981A (zh) 1999-03-24
BG63971B1 (bg) 2003-08-29
CN1089340C (zh) 2002-08-21
GR3036032T3 (en) 2001-09-28
CO4650040A1 (es) 1998-09-03
HRP970098A2 (en) 1999-04-30
WO1997030994A1 (fr) 1997-08-28
DZ2181A1 (fr) 2002-12-01
IS4803A (is) 1998-07-21
ID16642A (id) 1997-10-23
SK283461B6 (sk) 2003-08-05
KR19990087143A (ko) 1999-12-15
TR199801644T2 (xx) 1998-11-23
BG102699A (en) 1999-09-30
PE42798A1 (es) 1998-08-18
TW492961B (en) 2002-07-01
SK112398A3 (en) 2000-04-10
DE69704701T2 (de) 2001-08-16
HN1997000020A (es) 1997-06-05
AR005916A1 (es) 1999-07-21
NO313414B1 (no) 2002-09-30
US5977142A (en) 1999-11-02
AU712230B2 (en) 1999-11-04
JPH11504051A (ja) 1999-04-06
AP751A (en) 1999-07-12
AP9700930A0 (en) 1997-04-30
NO983871D0 (no) 1998-08-21
RU2162848C2 (ru) 2001-02-10
UA61068C2 (en) 2003-11-17
CA2247164C (fr) 2004-11-16
KR100315934B1 (ko) 2002-03-21
CZ267898A3 (cs) 1999-08-11
MY129729A (en) 2007-04-30
OA10838A (en) 2001-08-13
CA2247164A1 (fr) 1997-08-28
IL125413A0 (en) 1999-03-12
EP0885218B1 (fr) 2001-05-02
ES2156357T3 (es) 2001-06-16
EP0885218A1 (fr) 1998-12-23
PT885218E (pt) 2001-08-30
TNSN97039A1 (fr) 2005-03-15
HK1018274A1 (en) 1999-12-17
ZA971513B (en) 1998-08-21
JP3148252B2 (ja) 2001-03-19
AU1601497A (en) 1997-09-10
BR9707733A (pt) 1999-07-27
DE69704701D1 (de) 2001-06-07
PL186879B1 (pl) 2004-03-31
IL125413A (en) 2002-09-12
HUP9900501A2 (hu) 1999-06-28
HUP9900501A3 (en) 2001-02-28
YU35698A (sh) 1999-07-28
NZ331039A (en) 1999-10-28
NO983871L (no) 1998-08-21
GB9603755D0 (en) 1996-04-24
DK0885218T3 (da) 2001-05-28
CZ292650B6 (cs) 2003-11-12
PL328633A1 (en) 1999-02-15
ATE200899T1 (de) 2001-05-15

Similar Documents

Publication Publication Date Title
PL331534A1 (en) Muscarinic antagonists
CY2576B1 (en) Vitronectin receptor antagonists
HU9603525D0 (en) Vironectin receptor antagonists
EP0912175A4 (fr) Antagonistes du recepteur de fibrinogene
GB9020051D0 (en) Muscarinic receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
SG80041A1 (en) Muscarinic receptor antagonists
EP0915651A4 (fr) Antagonistes des recepteurs d'il-8
IL130760A0 (en) Vitronectin receptor antagonists
GR3036032T3 (en) Oxa- and thia-diazole muscarinic receptor antagonists
EP0885213A4 (fr) Antagonistes du recepteur du fibrinogene
EP0885205A4 (fr) Antagonistes des recepteurs de fibrinogenes
EP0907362A4 (fr) Antagonistes des recepteurs d'il-8
IL140249A0 (en) Muscarinic antagonists
IL135028A0 (en) Vitronectin receptor antagonists
GB9600344D0 (en) Benzimidzolyl neuropeptide y receptor antagonists
EP0920253A4 (fr) Antagonistes du recepteur il-8
ZA200003475B (en) Muscarinic receptor antagonists.
SI0957917T1 (sl) Antagonisti receptorja vitronektina
ZA961293B (en) Muscarinic antagonists
EP0957908A4 (fr) Antagonistes de recepteurs du fibrinogene
GB9603371D0 (en) Fibrinogen receptor antagonists
GB9606489D0 (en) Fibrinogen receptor antagonists
GB9613688D0 (en) Fibrinogen receptor antagonists
GB9603373D0 (en) Integrin receptor antagonists

Legal Events

Date Code Title Description
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
A1OB Publication of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20040119

Year of fee payment: 8

PBON Lapse due to non-payment of renewal fee

Effective date: 20050221